Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Treatment of high-grade glioma in children and adolescents
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-07-22 / Neuro-oncology 2011 Oct;13(10):1049-58Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies
/in International Publications, Micronutrients /von 2011-07-20 / Br J Haematol 2011 Aug;154(4):448-56Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-07-19 / Clin. Cancer Res. 2011 Sep;17(17):5725-35Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2011-07-01 / Immunotherapy 2011 Jul;3(7):805-7A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-06-28 / J Clin Neurosci 2011 Aug;18(8):1048-54Reirradiation and hyperthermia for radiation-associated sarcoma
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2011-06-28 / Cancer 2012 Jan;118(1):180-7Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages
/in Hyperthermia, International Publications /von 2011-06-23 / Radiother Oncol 2011 Oct;101(1):109-15Prostate cancer immunotherapy
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-06-23 / Clin. Cancer Res. 2011 Aug;17(16):5233-8Dendritic cell (DC) vaccination with low dose temozolomide phase I/II trial in melanoma patients: Preliminary data on peripheral blood regulatory t-cells (Treg) and DC-TEM8 expression modulations.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-06-17 / J Clin Oncol 29: 2011 (suppl; abstr e13029)Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study
/in Dendritic Cells, International Publications, NSCLC /von 2011-06-17 / J. Exp. Clin. Cancer Res. 2011 Jun;30:65Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2011-06-17 / Cancer Immunol. Immunother. 2011 Oct;60(10):1497-502Sipuleucel-T: autologous cellular immunotherapy for men with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-06-15 / J Cancer 2011;2:357-9Recent advances in immunotherapy for the treatment of prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-06-15 / Expert Opin Biol Ther 2011 Aug;11(8):997-1009Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-06-15 / Clin. Cancer Res. 2011 Jun;17(12):3884-91Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus.
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2011-06-06 / J Clin Oncol 29: 2011 (suppl; abstr 2508)Results of a phase I/II clinical trial of BPX-101, a novel drug-activated dendritic cell (DC) vaccine for metastatic castration-resistant prostate cancer (mCRPC).
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-06-05 / J Clin Oncol 29: 2011 (suppl; abstr 4670)Pilot immunotherapy trial in high-risk pediatric sarcomas.
/in Dendritic Cells, Soft Tissue Sarcoma /von 2011-06-05 / J Clin Oncol 29: 2011 (suppl; abstr 9541)Melanoma patients treated with dendritic cell vaccination, interleukin-2, and metronomic cyclophosphamide: Results from a phase II trial.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr e13084)A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr 2533)Survival rates among patients vaccinated following resection of colorectal cancer metastases in a phase II randomized study compared with contemporary controls.
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr 3557)